Explore our Services
- Venture Capital (VC)(2761)
Cardea is developing a Tech+Bio Infrastructure based on proprietary Biology-gated Transistors, or Cardean Transistors. Cardean Transistors leverage biocompatible graphene instead of silicon and replace optical signal observations with live-streams of multi-omics signal analysis. Until now, life science data was comprised of static snapshot datasets. Cardea uses Cardean Transistors to build chipsets that can be integrated into thousands of "Powered by Cardea" products and applications with features never before seen. Together with their Innovation Partners, Cardea can link biology to computers and measure real-time biological signals - allowing for a new generation of applications Linking up to Life.